Outlook Therapeutics Inc
F:41ON
Outlook Therapeutics Inc
F:41ON
Price:
1.537
EUR
-0.84%
Market Cap:
€347.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
Outlook Therapeutics Inc
F:41ON
|
US |
|
S
|
Scotts Miracle-Gro Co
F:SCQA
|
US |
|
Electrocomponents PLC
F:ECN
|
UK |
|
A
|
Aspo Oyj
F:ZYD
|
FI |
|
Tencent Music Entertainment Group
OTC:TCMEF
|
CN |
|
P
|
Petroleo Brasileiro SA Petrobras
MAD:XPBRA
|
BR |
|
V
|
Volatus Aerospace Inc
DUS:ABB
|
CA |
|
Country Garden Services Holdings Co Ltd
F:75H
|
CN |
Wall St Price Targets
41ON Price Targets Summary
Outlook Therapeutics Inc
Outlook Therapeutics Inc
Wall Street analysts forecast 41ON stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 41ON is 8.219 EUR with a low forecast of 0.977 EUR and a high forecast of 12.183 EUR.
Lowest Forecast
Price Target
0.977
EUR
36% Downside
Average Forecast
Price Target
8.219
EUR
435% Upside
Highest Forecast
Price Target
12.183
EUR
693% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41ON's stock price target?
Price Target
8.219
EUR
8.219
EUR
According to Wall Street analysts, the average 1-year price target for 41ON is 8.219 EUR with a low forecast of 0.977 EUR and a high forecast of 12.183 EUR.
What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%
55%
Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.
